米国市場銘柄情報

AADI アーディバイオサイエンシズ

銘柄追加

2.110
+0.110+5.50%

終値 05/07 16:00 ET

2.120
+0.010+0.47%

市場後 17:23 ET

5,180.94万時価総額-864直近PER

アーディバイオサイエンシズに関するコメント

ログインコメントを投稿

Moomoo AI

03/08 20:17

Aadi Bioscience's low P/S ratio may be due to its poor revenue outlook. Investors may believe the potential for revenue improvement doesn't justify a higher P/S ratio. These conditions could continue to limit the share price.

Aadi Bioscience, Inc.'s (NASDAQ:AADI) Shares Bounce 27% But Its Business Still Trails The Industry

Dobi1Kedobi

03/04 22:45

Great News

$アーディバイオサイエンシズ(AADI.US)$ get in now at 2 and get out around 2.5pt. Not fin advice

Stock_Drift

03/04 07:46

🚨⚡️🚨⚡️🚨 3/4/2024
$エンボイメディカル A(COCH.US)$ $CXアプリ A(CXAI.US)$ $アーディバイオサイエンシズ(AADI.US)$ $CURO Group(CURO.US)$ $ビッグベアーai(BBAI.US)$ $Fisker(FSR.US)$ $アイノス(AIMD.US)$
📊⚡️📊

Moomoo AI

2023/12/16 20:33

Low P/S ratio and poor stock performance of Aadi Bioscience is attributed to investor expectations of limited future growth. Higher revenues are necessary for an improved P/S.

Revenues Working Against Aadi Bioscience, Inc.'s (NASDAQ:AADI) Share Price Following 48% Dive

Moomoo AI

2023/11/16 18:35

The substantial cut in revenue forecasts indicates a less optimistic outlook on Aadi Bioscience, which may trigger investors to begin selling their holdings. The drop in the consensus price target is another bearish signal on Aadi Bioscience's future valuation.